Synthesized peptide derived from the C-terminal region of human TBC1D3A/B/C.
Species Reactivity:
Human
Tested Applications:
WB, ELISA;WB:1/500-1/2000.ELISA:1/20000
Clonality:
Polyclonal
Isotype:
IgG
Conjugate:
Non-conjugated
Buffer:
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Form:
Liquid
Stroage:
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Aliases:
TBC1D3; PRC17; TBC1D3A; TBC1 domain family member 3; Prostate cancer gene 17 protein; Protein TRE17-alpha; Rab GTPase-activating protein PRC17; TBC1D3B; TBC1D3I; TBC1 domain family member 3B; TBC1D3C; TBC1D3D; TBC1 domain family member 3C
UniprotID:
Q8IZP1/A6NDS4/Q6IPX1
Purification Method:
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
BufferLiquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
FormLiquid
StroageUpon receipt, store at -20°C or -80°C. Avoid repeated freeze.
AliasesTBC1D3; PRC17; TBC1D3A; TBC1 domain family member 3; Prostate cancer gene 17 protein; Protein TRE17-alpha; Rab GTPase-activating protein PRC17; TBC1D3B; TBC1D3I; TBC1 domain family member 3B; TBC1D3C; TBC1D3D; TBC1 domain family member 3C
UniprotIDQ8IZP1/A6NDS4/Q6IPX1
Purification MethodThe antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.